New PSA guidelines aim to cut unnecessary biopsies
NCT ID NCT04782713
First seen Feb 01, 2026 · Last updated May 12, 2026 · Updated 16 times
Summary
This study tested new guidelines for PSA screening in 49 men aged 40-75 with elevated PSA levels. The goal was to improve how doctors decide when to start and stop screening, how often to repeat it, and when to refer for biopsy. Researchers compared PSA test rates, biopsy complications, and cancer detection before and after the guidelines were introduced.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mile Square Health Center
Chicago, Illinois, 60612, United States
Conditions
Explore the condition pages connected to this study.